Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,019,664
-$1,583,070 QoQ
Shares Held
16,069
+7.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#294
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethic Inc. holds $40,271,041 across 35 Biotechnology names. REGN ranks #2 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,947 | $10,405,003 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
16,069 | $10,019,664 | |
| 3 | ARGX |
Argenx SE
|
4,376 | $4,059,921 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
31,679 | $2,511,827 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,965 | $1,615,628 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,172 | $1,556,927 | |
| 7 | MRNA |
Moderna, Inc.
|
15,694 | $1,099,050 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
9,345 | $885,438 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,019,664 | 16,069 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $11,602,734 | 15,017 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $12,305,923 | 15,943 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,273,519 | 16,493 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $8,844,675 | 16,847 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,490,982 | 7,081 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,599,136 | 10,668 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,474,587 | 6,159 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,771,786 | 6,443 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,927,975 | 6,159 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,880,657 | 5,557 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,787,981 | 5,818 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,053,284 | 5,641 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,585,740 | 5,581 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,388,131 | 3,310 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,676,709 | 2,434 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,460,682 | 2,471 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,347,252 | 1,929 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $963,068 | 1,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $843,015 | 1,393 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $579,764 | 1,038 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $353,908 | 748 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $418,856 | 867 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $460,139 | 822 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $374,813 | 601 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $229,984 | 471 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||